| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-04-19 | Direct Genomics | Series A | $34.72M | Xiyi Asset Management |
| 2017-08-30 | Shuidihuzhu | Series A | $24M | BlueRun Ventures, Gaorong Capital, IDG Capital, Meituan, Sinovation Ventures, and Tencent Holdings |
| 2017-08-15 | Ankon Technologies | Unattributed VC | $100M | Da Zhong Investment Group Co., Houxin Health Investment, PreIPO, Qiansheng Investment, and Softbank China Venture Capital |
